You are currently logged into
Cancer Health Directory - My Account or Log Out

Home
News
- News
- Newsfeed
- Science News
- Features
- Opinions
- Conferences
- Slideshows
- Cancer Health TV
- By Author
- RSS Links
Cancer Basics
Hot Topics
Magazine
Blogs
Community
About Us
- About Us
- Masthead
- Advertise
- Awards
- Contact Us
Facebook
Twitter

© 2023 Smart + Strong.
All Rights Reserved.
Terms of use and
Your privacy.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.

Twitter

Facebook

Tumblr

#Perjeta

FDA Approves Enhertu for HER2-Positive Advanced Breast Cancer

60% of women treated with the antibody-drug conjugate experienced complete or partial tumor shrinkage.

Margetuximab May Offer New Option for Metastatic Breast Cancer

The novel immune-enhancing antibody delays disease progression, especially in people with a common genetic variant.

Perjeta

Stay Logged In?

You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.

You Have Been Logged Out

Click here to log back in.

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

Cancer Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.